Paper36959736
Lack of Causal Associations of Inflammatory Bowel Disease with Parkinson's Disease and Other Neurodegenerative Disorders.
Zeng R and 10 others. Mov Disord, 2023. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Lack of Causal Associations of Inflammatory Bowel Disease with Parkinson's Disease and Other Neurodegenerative Disorders. Papers, record 36959736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36959736
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Parkinson Disease | Major topic |
| Neurodegenerative Diseases | Major topic |
| Alzheimer Disease | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Humans | |
| Genome-Wide Association Study | |
| Mendelian Randomization Analysis |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42630799 | The potential connection between inflammatory bowel disease and Alzheimer's disease: mechanistic insights and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42630799 | PubMed |
| 42136685 | Interpretable hybrid deep learning model for Parkinson's disease screening using hand-drawn spiral and waveform images. | Pol J Radiol | 2026 | https://conductscience.org/library/papers/42136685 | PubMed |
| 41776457 | Classifying drug-related problems of neurodegenerative diseases in the physician-pharmacist joint clinic of neurology: an application of the PCNE method. | BMC Geriatr | 2026 | https://conductscience.org/library/papers/41776457 | PubMed |
| 41220184 | Causal Relationship Between Inflammatory Bowel Disease and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study. | Brain Behav | 2025 | https://conductscience.org/library/papers/41220184 | PubMed |
| 41088409 | Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapies. | Mol Neurodegener | 2025 | https://conductscience.org/library/papers/41088409 | PubMed |
| 41017969 | Microbiome-Gut-Brain Axis: Implications for the Links Between Inflammatory Bowel Disease and Neuropsychiatric Disorders. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41017969 | PubMed |
| 40332115 | Evaluating the Bidirectional Causal Effects of Alzheimer's Disease Across Multiple Conditions: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332115 | PubMed |
| 40243562 | Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40243562 | PubMed |
| 40199927 | Impact of anti-VZV IgG levels on Parkinson's disease risk and progression: a Mendelian randomization analysis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40199927 | PubMed |
| 40178608 | Decoding the genetic links between substance use disorder and cancer vulnerability. | Psychopharmacology (Berl) | 2025 | https://conductscience.org/library/papers/40178608 | PubMed |
| 39976770 | Curcumin protects against MPP+-induced neurotoxicity in SH-SY5Y cells by modulating the TRPV4 channel. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39976770 | PubMed |
| 39799347 | Possible linking and treatment between Parkinson's disease and inflammatory bowel disease: a study of Mendelian randomization based on gut-brain axis. | J Transl Med | 2025 | https://conductscience.org/library/papers/39799347 | PubMed |
| 38891863 | From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38891863 | PubMed |
| 38879999 | Update: Protective and risk factors for Parkinson disease. | Parkinsonism Relat Disord | 2024 | https://conductscience.org/library/papers/38879999 | PubMed |
| 38854967 | Bidirectional communication of the gut-brain axis: new findings in Parkinson's disease and inflammatory bowel disease. | Front Neurol | 2024 | https://conductscience.org/library/papers/38854967 | PubMed |
| 38769320 | Causal effect of blood osteocalcin on the risk of Alzheimer's disease and the mediating role of energy metabolism. | Transl Psychiatry | 2024 | https://conductscience.org/library/papers/38769320 | PubMed |
| 38741190 | The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson's disease comorbidity. | Genome Med | 2024 | https://conductscience.org/library/papers/38741190 | PubMed |
| 38373892 | Investigating the shared genetic architecture between primary sclerosing cholangitis and inflammatory bowel diseases: a Mendelian randomization study. | BMC Gastroenterol | 2024 | https://conductscience.org/library/papers/38373892 | PubMed |
| 38288279 | Association between inflammatory bowel disease and Parkinson's disease: a prospective cohort study of 468,556 UK biobank participants. | Front Aging Neurosci | 2023 | https://conductscience.org/library/papers/38288279 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36959736
GET https://conductscience.org/api/papers/v1/36959736/authors